Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?
- 1 January 2002
- journal article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 30 (1) , 58-68
- https://doi.org/10.1111/j.1748-720x.2002.tb00720.x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The Ethical Problems with Sham Surgery in Clinical ResearchNew England Journal of Medicine, 1999
- Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's DiseaseNew England Journal of Medicine, 1999
- Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory MythsJournal of Law, Medicine & Ethics, 1996
- Placebo Orthodoxy in Clinical Research I: Empirical and Methodological MythsJournal of Law, Medicine & Ethics, 1996
- The effect of deprenyl and levodopa on the progression of Parkinson's diseaseAnnals of Neurology, 1995
- Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseAnnals of Neurology, 1995
- SCIENTIFIC AND ETHICAL ISSUES IN THE USE OF PLACEBO CONTROLS IN CLINICAL TRIALSAnnual Review of Public Health, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987
- Are Randomized Trials Appropriate for Evaluating New Operations?New England Journal of Medicine, 1979